The Anti-Epilepsy Drugs Market is expected to reach USD 4.8 billion with a CAGR of 3.7% owing to rising occurrence of the epilepsy and advancements in drugs modification over the forecast period 2017-2022. The Increasing geriatric population worldwide is an important factor in boosting the demand for anti-epilepsy drugs.
it is expected that nearly 75% of the people with epilepsy live in middle & low-income countries. Favorable government initiative and approval of several late-stage pipeline molecules fuels the anti-epileptic drugs market growth. However, increasing generic competition and patent expiration and side effects related to the therapeutic drugs, are some of the restrains that for the growth during the forecast period.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/2345
Anti-Epilepsy Drugs Market Segmentation Analysis
The segmentation of the anti-epileptic drugs market is carried out by
- types of seizure
The segmentation by types of seizures includes
- partial-onset seizures
- generalized seizures.
The segmentation of the anti-epileptic drugs market by generation
Anti-Epileptic Drugs Market Detailed Regional Analysis
- Asia Pacific
Americas leads the global anti-epilepsy drugs market owing to increasing occurrence of epilepsy, advancement of technologies within the region and well-developed healthcare sector.
Europe is second in the anti-epileptic drugs market due to rising healthcare R&D expenses by the government, huge patient population and growing healthcare expenditures.
The Asia Pacific region is the fastest growing anti-epilepsy drugs market due to the developing economies like China and India which are increasing their healthcare expenditures and have huge patient population.
Middle East and Africa have the least anti-epilepsy drugs market share, especially due to the presence of poor economies and stringent government policies within the African region.
Anti-Epilepsy Drugs Market Key Players
- Abbott Laboratories,
- Johnson & Johnson,
- GlaxoSmithKline plc,
- UCB Pharma Ltd.,
- Sanofi S.A.,
- Pfizer, Inc.,
- Novartis International AG,
- Shire Pharmaceuticals Limited
- Cephalon Inc.
Table of Content
- Scope of Study
- Research Objective
- Assumptions & Limitations
- Market Structure
- Research Process
- Primary Research
- Secondary Research
Anti-Epileptic Drugs Market Dynamics
- Macroeconomic Indicators
Browse Full Research Report at: https://www.marketresearchfuture.com/reports/anti-epilepsy-drugs-market-2345
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312